Sep 5, 2026Foreign-headquartered CMOs expand US capacity | Curia’s Albuquerque expansion

Sep 4, 2026Evonik bolsters North America network | Lifecore secures commercial site transfer agreement

Sep 3, 2026ARPA-H funds genetic medicines on demand | Andelyn scales gene therapy manufacturing

Sep 2, 2026Trump’s 9 new drug pricing, tariff deals | Syntegon opens OSD customer center

Sep 1, 2026Continuous upstream bioprocessing grows | WuXi XDC’s Singapore site achieves milestone

Aug 29, 2026Samsung Biologics to raise $2.2B | BMS to build $173M Indiana radiopharma plant

Aug 28, 2026WuXi Biologics expands capacity | Artis BioSolutions’ new genetic medicines center

Aug 27, 2026What’s next for Cellares after losing BMS? | Aurigene inks deal with global pharma company

Aug 26, 2026BMS ends partnership with Cellares | Cambrex’s NC site clears inspections

Aug 25, 2026WuXi XDC reports strong growth | WuXi Biologics divests chromatography unit

Aug 22, 2026Siegfried’s US acquisition boosts CDMO network | Genentech’s $750M Oregon expansion

Aug 21, 2026FDA slaps Xspray Pharma with CRL | Genentech completes structural framework of NC site

Aug 20, 2026Peptide sponsors turn to CDMOs earlier | SK pharmteco’s facility expansions in Ireland

Aug 19, 2026German drugmakers under threat | WuXi XDC achieves GMP release at Singapore site

Aug 18, 2026Bora’s US growth strategy | Lonza launches rapid media prototyping service

Aug 15, 2026Halo’s new $45M fill-finish platform | Eurofins CDMO Alphora’s kilolab, HPAPI expansion

Aug 14, 2026FDA’s onshoring of generic drugs, APIs | Generic oligonucleotide API maker passes inspection

Aug 13, 2026Catalent launches enterprise AI tool | PerkinElmer’s Project Farma acquires SimoTech

Aug 12, 2026WuXi AppTec is victim of US-China relations | MilliporeSigma biosafety testing lab expansion

Aug 11, 2026BMS invests $2.3B in new Houston site | Novo Nordisk’s troubled Indiana facility

Aug 8, 2026Brewing drug ingredients like beer | Altruist’s PPQ campaign on 20,000L bioreactors

Aug 7, 2026Increasing demand for fill-finish manufacturing | AstraZeneca, CSPC form joint China venture

Aug 6, 2026Greg Slabodkin Lifecore to see jump in fill-finish demand | AsymBio to boost biologics CDMO capacity

Aug 5, 2026WuXi AppTec ups CapEx to boost global capacity | Piramal expands peptide API facility

Aug 4, 2026Samsung reports growth on full plant operations | CordenPharma closes AmbioPharm acquisition

Latest Edition